Information:
Error:
ID
22714
Description
Study to Measure Drug Satisfaction of Patients With Schizophrenia After Switching From Risperidone to Paliperidone; ODM derived from: https://clinicaltrials.gov/show/NCT00535132
Link
https://clinicaltrials.gov/show/NCT00535132
Keywords
Versions (1)
- 6/10/17 6/10/17 -
Uploaded on
June 10, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Schizophrenia NCT00535132
Eligibility Schizophrenia NCT00535132
- StudyEvent: Eligibility
Similar models
Eligibility Schizophrenia NCT00535132
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
informed consent
Item
must be able to understand, in the opinion of the investigator, the informed consent form.
boolean
C0021430 (UMLS CUI [1])
schizophrenia
Item
be diagnosed with schizophrenia
boolean
C0036341 (UMLS CUI [1])
report dissatisfaction with current medication
Item
report dissatisfaction with current medication
boolean
C4049186 (UMLS CUI [1])
schizophrenia management, benefit from a change in antipsychotic medication
Item
have an aspect of schizophrenia management which could potentially benefit from a change in antipsychotic medication
boolean
C0036341 (UMLS CUI [1,1])
C0376636 (UMLS CUI [1,2])
C0814225 (UMLS CUI [2,1])
C0580105 (UMLS CUI [2,2])
C0040615 (UMLS CUI [2,3])
C0376636 (UMLS CUI [1,2])
C0814225 (UMLS CUI [2,1])
C0580105 (UMLS CUI [2,2])
C0040615 (UMLS CUI [2,3])
risperidone duration
Item
receive risperidone 4 mg or 6 mg for at least 4 weeks before the start of the study.
boolean
C0073393 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,2])
ability to swallow study drug
Item
unable to swallow study drug whole with the aid of water
boolean
C0566355 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
study subject participation status
Item
cannot have received an investigational drug, used an investigational medical device, or participated in a clinical study that altered their medication within 6 months before the first administration of study drug, or have participated in more than 2 investigational drug studies within the past 12 months
boolean
C2348568 (UMLS CUI [1])
other mental disorders, except for tobacco dependance
Item
no other major mental health diagnosis except for tobacco dependance
boolean
C0338607 (UMLS CUI [1])
C0543414 (UMLS CUI [2])
C0543414 (UMLS CUI [2])
cocaine, heroin
Item
no use of cocaine or heroin within 3 months before the first administration
boolean
C0009170 (UMLS CUI [1])
C0011892 (UMLS CUI [2])
C0011892 (UMLS CUI [2])
no prior therapy with any antipsychotic, treatment with risperidone, treatment with paliperidone
Item
no history of treatment with any antipsychotic in addition to treatment with risperidone, or treatment with paliperidone, within 30 days before the baseline visit.
boolean
C1514463 (UMLS CUI [1,1])
C0040615 (UMLS CUI [1,2])
C0073393 (UMLS CUI [1,3])
C0753678 (UMLS CUI [1,4])
C0040615 (UMLS CUI [1,2])
C0073393 (UMLS CUI [1,3])
C0753678 (UMLS CUI [1,4])